0001840655-24-000002.txt : 20240618 0001840655-24-000002.hdr.sgml : 20240618 20240618160854 ACCESSION NUMBER: 0001840655-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240618 DATE AS OF CHANGE: 20240618 EFFECTIVENESS DATE: 20240618 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NephroDI Therapeutics, Inc. CENTRAL INDEX KEY: 0001840655 ORGANIZATION NAME: IRS NUMBER: 822363611 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-516337 FILM NUMBER: 241051802 BUSINESS ADDRESS: STREET 1: 2200 32ND AVE W CITY: SEATTLE STATE: WA ZIP: 98199 BUSINESS PHONE: 206-696-0546 MAIL ADDRESS: STREET 1: 2200 32ND AVE W CITY: SEATTLE STATE: WA ZIP: 98199 D 1 primary_doc.xml X0708 D LIVE 0001840655 NephroDI Therapeutics, Inc. 2200 32ND AVE W SEATTLE WA WASHINGTON 98199 206-696-0546 DELAWARE None None Corporation true Rachael Hagan 2200 32nd Ave W Seattle WA WASHINGTON 98199 Executive Officer Director Michael Grissinger 2200 32nd Ave W Seattle WA WASHINGTON 98199 Director Jeff M. Sands, M.D. 2200 32nd Ave W Seattle WA WASHINGTON 98199 Executive Officer Bibhash Mukhopadhyay 2200 32nd Ave W Seattle WA WASHINGTON 98199 Director Pharmaceuticals Decline to Disclose 06b false 2024-06-11 true true false 0 3999999 2000000 1999999 false 2 0 0 2113000 true Estimated amount assumes the Issuer will raise the Total Offering Amount false NephroDI Therapeutics, Inc. Rachael Hagain Rachael Hagan President 2024-06-11